What is NDC 51662-1316?

51662-1316 is the product NDC for Dopamine Hydrochloride, Dopamine hydrochloride 1.6 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dopamine Hydrochloride?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dopamine Hydrochloride NDC 51662-1316 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1316Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1316Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1316-1	51662131601	250 mL in 1 BAG (51662-1316-1)Marketed from Oct 19, 2018
51662-1316-3	51662131603	12 POUCH in 1 CASE (51662-1316-3) / 1 BAG in 1 POUCH (51662-1316-2) / 250 mL in 1 BAGMarketed from Sep 12, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dopamine Hydrochloride
Generic name (nonproprietary): dopamine hydrochloride
Active ingredients: Dopamine hydrochloride — 1.6 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018826
Marketing start: Oct 19, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Catecholamines (Chemical structure)
Identifiers: Product ID 51662-1316_101df49b-fde7-ec91-e063-6294a90a8a90SPL ID 101df49b-fde7-ec91-e063-6294a90a8a90SPL set ID 7896052c-2a72-ca89-e053-2a91aa0ae86eRxCUI 1743877UNII 7L3E358N9L
Pharmacologic class: Catecholamine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662131601 followed by a unit qualifier and the quantity

Package 51662-1316-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE Dopamine Hydrochloride in 5% Dextrose Injection, USP is indicated for the correction of hemodynamic imbalances present in shock due to myocardial infarction, trauma, endotoxic septicemia, open heart surgery, renal failure and chronic cardiac decompensation as in refractory congestive failure. When indicated, restoration of circulatory volume should be instituted or completed with a suitable plasma expander or whole blood, prior to administration of dopamine hydrochloride. Patients most likely to respond to dopamine are those whose physiological parameters (such as urine flow, myocardial function and blood pressure) have not undergone extreme deterioration. Reports indicat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1316

What is NDC 51662-1316?: 51662-1316 is the product NDC for Dopamine Hydrochloride, Dopamine hydrochloride 1.6 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dopamine Hydrochloride.
What is the active ingredient?: Dopamine hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dopamine Hydrochloride?: 14 other product NDCs are listed under this name. See all Dopamine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dopamine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dopamine Hydrochloride	Dopamine hydrochloride 40 mg/mL	Injection, Solution, ConcentrateIntravenous	Henry Schein, Inc.	0404-9982	00404-9982-05
Dopamine Hydrochloride	Dopamine hydrochloride 40 mg/mL	Injection, Solution, ConcentrateIntravenous	Henry Schein, Inc.	0404-9981	00404-9981-10
Dopamine Hydrochloride	Dopamine hydrochloride 40 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1489	51662-1489-0151662-1489-03
Dopamine Hydrochloride	Dopamine hydrochloride 40 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1490	51662-1490-01
Dopamine Hydrochloride	Dopamine hydrochloride 40 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9252	00143-9252-25
Dopamine Hydrochloride	Dopamine hydrochloride 80 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9253	00143-9253-25
Dopamine Hydrochloride	Dopamine hydrochloride 40 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9254	00143-9254-25
Dopamine Hydrochloride	Dopamine hydrochloride 80 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9255	00143-9255-25
Dopamine Hydrochloride	Dopamine hydrochloride 40 mg/mL	InjectionIntravenous	ProPharma Distribution	84549-252	84549-0252-25
Dopamine Hydrochloride	Dopamine hydrochloride 40 mg/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7305	71872-7305-01

All 15 Dopamine Hydrochloride NDCs

Other NDCs under NDA 018826

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018826
Product	Strength	Form · route	Labeler	Product NDC
Dopamine Hydrochloride in Dextrose	Dopamine hydrochloride 1.6 mg/mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-7809
Dopamine Hydrochloride in Dextrose	Dopamine hydrochloride 3.2 mg/mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-1858
Dopamine Hydrochloride in Dextrose	Dopamine hydrochloride 1.6 mg/mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-0042
dopamine hydrochloride in dextrose	Dopamine hydrochloride 1.6 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1681